GLP-1’s may be thinning more than just men’s waistlines, a shocking new review has found.
Drugs like Ozempic and Zepbound have exploded into the mainstream market—but so have anecdotal reports of hair thinning among patients, says a systematic review published in Science Progress.
The review found that male patients were seven percent more likely to experience hair loss if they had higher amounts of the gene that GLP-1 medications create.
The post Scientists Flag New Concern for Men on GLP-1 Drugs appeared first on The Daily Beast
